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Despite the inclusion of sexual and reproductive health (SRH) services in the minimum stan-
dards of health care in humanitarian settings, access to SRH services, and especially to
contraception, is often compromised in war. Very little is known about continuation and
switching of contraceptive methods in these settings. An evaluation of a contraceptive ser-
vices program in North Kivu, Democratic Republic of the Congo (DRC) was conducted to
measure 12-month contraceptive continuation by type of contraceptive method (short-acting
or long-acting).
Methods
A stratified systematic sample of women who initiated a contraceptive method 12–18
months prior to data collection was selected retrospectively from facility registers. A total of
548 women was interviewed about their contraceptive use: 304 who began a short-acting
method (pills, injectables) and 244 who began a long-acting method (intra-uterine devices,
implants). Key characteristics of short-acting method versus long-acting method acceptors
were compared using chi-square statistics for categorical data and t-tests for continuous
data. Unadjusted and adjusted Cox proportional hazard ratios were estimated to assess fac-
tors associated with discontinuation.
Results
At 12 months, 81.6% women reported using their baseline contraceptive method continu-
ously, with more long-acting than short-acting contraceptive acceptors (86.1% versus
78.0%, p = .02) continuing contraceptive use. Use of a short-acting method (Hazard ratio
(HR) 1.74 [95%CI 1.13–2.67]) and desiring a child within two years (HR 2.58 [95%CI 1.45–
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4.54]) were associated with discontinuation within the first 12 months of use. The vast major-
ity (88.3%) of women reported no prior contraceptive use.
Conclusion
This is the first study of contraceptive continuation in a humanitarian setting. The high per-
centages of women continuing contraceptive use found here demonstrates that women will
choose to initiate and continue use of their desired contraceptive method, even in a difficult,
unstable and low contraceptive prevalence setting like North Kivu.
Introduction
The complex humanitarian emergencies caused by armed conflict are characterized by social
disruption, population displacement and the breakdown of national health systems [1, 2]. In
addition to their need for shelter, food, water and primary health care, women living in
humanitarian settings face many sexual and reproductive health (SRH) concerns including
high risk of mortality and morbidity due to pregnancy-related causes, unintended pregnancy
due to lack of information or access to contraceptive services, complications of unsafe abor-
tions, gender-based violence and sexually transmitted infections including HIV [3]. Humani-
tarian assistance standards now recognize this increased risk and SRH services are included in
the minimum package of care [4].
Although access to SRH services has improved in humanitarian settings, a 2012–2014 eval-
uation of SRH in humanitarian settings showed limited progress for contraceptive services rel-
ative to other SRH components [5]. Only 14.9% of the humanitarian health appeals from
2009–2013 requested funding for contraceptive services, the smallest share of any of the SRH
components; contraceptive services subsequently received the lowest dollar amount among
SRH components (US$76.3 million out of US$1.5 billion) [6]. Further, long-acting and perma-
nent contraceptive methods were rarely mentioned in the appeals. The 2012–2014 evaluation
also found that 36 of the 63 health facilities assessed in three humanitarian settings provided
pills and injectables, and only 11 met the minimum quality criteria to provide long-acting con-
traceptives [7]. Overall, the findings of the 2012–2014 global evaluation reflected the limited
attention given to the provision of contraceptive services in humanitarian settings.
Recent evidence suggests that contraceptives, including a broad range of methods, can be
effectively provided and will be used by women and men in humanitarian settings [8–10].
However, no data on contraceptive continuation in these settings exists. Effective contracep-
tive programs not only help women to initiate methods when they desire, but also ensure that
women are satisfied with their contraceptive method or help them switch to a new one, and
encourage continuity of their preferred method as long as they wish. An analysis of 60 Demo-
graphic and Health Surveys (DHS) from 25 countries in Africa, Asia, Eastern Europe and
Latin America found that over one-third of women discontinued their contraceptive method
by 12 months of use, with 17% - 62% stopping due to method-related reasons including side
effects [11]. Discontinuation is generally higher for hormonal contraceptives, for short-acting
methods, and among younger women [11–13]. Evidence suggests that the availability of a
broader range of contraceptive methods is associated with lower discontinuation by making it
easier for women to switch to a different method if they are dissatisfied with their original
choice [14, 15]. Although research on the specific association between contraceptive service
provision and discontinuation is mixed [16], an analysis of DHS data from 15 countries found
Twelve-month contraceptive continuation in North Kivu, DRC
PLOS ONE | https://doi.org/10.1371/journal.pone.0182744 September 8, 2017 2 / 17
Competing interests: The authors have declared
that no competing interests exist.
that 7%-27% of women discontinued their contraceptive method in the first year for reasons
related to the quality of the service delivery, most of which could be addressed through quality
improvement activities [17]. Overall, the evidence suggests that service quality and contracep-
tive continuation are associated [15, 17, 18], but no research has addressed the specific needs
of women in unstable or conflict settings and how best to support them to continue contracep-
tive use and avoid unintended pregnancies.
Context and program description
Two decades of war and instability in the eastern region of the Democratic Republic of the
Congo (DRC) have resulted in a compromised health system. The population of the province
of North Kivu continues to be exposed to high levels of violence and displacement [19]. DRC
has the sixth highest maternal mortality ratio in the world at 730 maternal deaths per 100,000
live births [20], and is characterized by low contraceptive use. The 2014 DHS found that mod-
ern contraceptive prevalence was 7.8% nationally, 11.6% in North Kivu and 4.6% in rural
areas, with male condoms the most commonly used modern method [21]. Use of long-acting
and permanent contraceptive methods was very low at 1.7% nationally, 5.5% in North Kivu
and 1.1% in rural areas. Unmet need for contraception in North Kivu is 37.5%, and 28.8% of
women nationally reported an unintended pregnancy in the previous five years. Since 2012,
the DRC government has made a greater commitment to improve contraceptive services; this
has yet to diffuse to the provincial level [22].
Save the Children, in collaboration with Columbia University’s Reproductive Health
Access, Information and Services in Emergencies (RAISE) Initiative [23], began supporting
the Ministry of Health (MOH) to provide contraceptive services and post-abortion care in 34
public health facilities in three rural health zones of North Kivu, DRC in July 2011, and in five
facilities in Goma, the provincial capital, in November 2012. Short- and long-acting reversible
contraceptive methods (pills, injectables, condoms, intra-uterine devices (IUDs) and implants)
were introduced at health centers and hospitals. Training on permanent methods in 2015
made male and female sterilization more available at the hospitals. All contraceptive methods
were provided free of charge in the supported facilities.
Program support to the health facilities addressed Bruce’s fundamental elements of quality
for contraceptive services: availability of a range of short- and long-acting methods, compe-
tency-based clinical training for providers, training on contraceptive counselling, provision of
essential equipment and supplies and improved monitoring and evaluation [24]. Mechanisms
to improve continuation of contraceptive method use and follow-up of short-acting method
users were put in place. Once the services were established, the program expanded its focus on
quality improvement. Two in-depth program reviews were conducted by RAISE staff to iden-
tify areas needing improvement and to help program and MOH staff develop ways of address-
ing them.
The program provided essential equipment, supplies and contraceptives to the facilities,
primarily through the health zone MOH office. Nurses were trained to provide short- and
long-acting contraceptives to ensure their availability at health center level. All clinical training
organized by the program was competency-based, meaning each provider practiced on ana-
tomic models and live clients under observation by skilled trainers until competence was
attained.
The program focused on introducing high quality contraceptive services and helping clients
to start a method. However, they recognized that it is also important to support women to con-
tinue use of the contraceptive method that best suits them. Understanding the reasons clients
discontinue or continue contraceptive methods can help improve programs and ultimately
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contribute to helping them to effectively plan their families. Therefore, the program conducted
an evaluation to measure 12-month contraceptive continuation.
Methodology
Study design and sample
This evaluation used retrospective data from Save the Children-supported MOH health facili-
ties in Mweso and Masisi health zones, DRC. More than 50,000 modern contraceptive initia-
tions occurred between June 2011 and December 2015 at the 34 supported MOH facilities;
58% initiated a long-acting reversible contraceptive (LARC): IUD or implant (Fig 1). Nine
Save the Children-supported MOH facilities were selected for this evaluation because most of
the villages in their catchment areas were accessible during rainy season when the survey was
conducted and security was sufficient for the interviewers to safely travel and locate the clients.
A sample of women, aged 18 or older, who initiated a short-acting (pills, injectables) or long-
acting (IUDs, implants) contraceptive method 12–18 months prior to data collection was
drawn from the registers of these facilities. A sample size of 211 short-acting method acceptors
and 306 LARC acceptors was selected to detect (with 95% confidence and 80% power) a 13%
difference between short-acting and LARC acceptors based on documented contraceptive dis-
continuation at 12 months [25–27]. We used stratified systematic sampling with different
selection fractions for each method to ensure a minimum of 100 clients for each contraceptive
method. Contraceptive acceptors from June through August 2014 (May through August for
IUD clients) were identified. Data on the contraceptive method the woman chose, the date she
started the method, her name, age and village name were extracted. We extracted a sample
from the registers larger than needed to account for anticipated difficulties locating women for
interviews given the unstable population and far distances. Women whose village was outside
the catchment area of the facility, whose village was largely inaccessible or for whom the infor-
mation in the register was insufficient to locate them were then deleted from the sampling
frame.
Once data collection began, new militia movements prevented access to one facility and its
catchment area. In addition, the use of community health workers (CHWs) to locate clients
was found to be infeasible in the urban location of three selected facilities. Four additional
Fig 1. Distribution of contraceptive method initiations, Save the Children program, DRC, Jun
2011-Dec 2015. This represents contraceptive method initiations rather than individual women.
https://doi.org/10.1371/journal.pone.0182744.g001
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rural facilities were selected to replace these four facilities. Because these facilities had lower cli-
ent loads than the original four, the team extracted all clients who started one of the four con-
traceptive methods from April through September 2014 (implants for May through August
only). Due to the lower client numbers in the replacement facilities, the team returned to the
other facilities already included and extracted client data from additional months: all IUD, pill
and injectable clients from April and May, and all contraceptive starters for September 2014.
Study procedures
The 87-question quantitative survey questionnaire included topics such as demographic char-
acteristics; birth history; current reproductive intentions; partner involvement in contraceptive
decision-making; date of, experience with and reasons for discontinuation and/or switching of
methods; future intention to use for discontinuers; and continuers’ experience of problems
with their method. Women were asked about the quality of the information received at con-
traceptive method initiation including if the provider explained how to use the method, possi-
ble side effects, what to do in case of side effects and responded to all of her questions.
Questions were also asked about satisfaction with the services received at time of contraceptive
initiation and at any later point (e.g., if she returned because of problems with the method).
Questions were taken from pre-existing French sources for this study [28, 29] whenever possi-
ble with adaptations of the response options for the local context. The questionnaire was devel-
oped in French, and then translated into two languages: Congolese Swahili and Kinyarwanda.
These translations were then reviewed by the study team for accuracy. The questionnaire was
piloted among clients not included in the study sample.
The study team worked with the providers at the facilities and affiliated CHWs to locate the
selected women. CHWs or nurses visited the selected women in their homes to ask if they
were willing to discuss their use of health services at the facility with an interviewer. According
to MOH policy and current practice, these CHWs already visit women in their homes to dis-
cuss their health care and remind them of follow-up appointments for contraception so it was
not unusual for the CHWs to visit women at home. The CHWs were told that the women
were selected as clients of the health facility, not as contraceptive acceptors, to maintain their
confidentiality. Once a woman agreed to participate, a trained female interviewer interviewed
her in private. Women who lived more than a one hour walk from the facility were invited to
an interview at the facility or at a location mid-way between. These women who were inter-
viewed at a location outside their villages were given a sachet of salt and a bar of soap to reim-
burse their travel time. Data collection took place in October and November 2015.
Ethical considerations
Ethical approvals for the study were obtained from the Institutional Review Board (IRB) of the
Mailman School of Public Health, Columbia University, the Ethical Review Committee of Save
the Children and the North Kivu Provincial MOH. Interviewers read a consent script to the
client and obtained her verbal consent before commencing the interview. If the client indi-
cated that she did not wish to participate, she was thanked for considering involvement in the
study and no further questions were asked of her. Participant names were not entered on sur-
vey questionnaires to preserve anonymity, and records used to locate the client were destroyed
once she was located. A waiver of written consent was obtained from the IRB to preserve par-
ticipant anonymity. The program intervention is funded by an anonymous private foundation.
The donor had no role in study design, data collection, analysis or interpretation of the
findings.
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Statistical analysis
Data were entered into CSPro 6.0 and subsequently exported to PASW (SPSS) Version 23 for
cleaning and analysis. Discontinuation is defined as women reporting that they stopped con-
tinuous use of their baseline contraceptive method within 12 months of accepting the method.
Two women who were missing dates for discontinuation were excluded from the analysis. Key
socio-demographic characteristics of short-acting method versus LARC acceptors were com-
pared using chi-square statistics for categorical data and t-tests for continuous data. Where sig-
nificant differences were found, the characteristics were compared by contraceptive method
using Pearson chi-squares or one-way analysis of variance. Kaplan-Meier estimates of the
probability of discontinuation stratified by type of baseline contraceptive method (short-acting
or LARC) were plotted; the Wilcoxon (Breslow) test was used to assess differences in the sur-
vival curves. Censoring occurred when the woman reported that she stopped continuous use
of her baseline contraceptive method.
Unadjusted and adjusted Cox proportional hazard ratios were estimated to assess factors
associated with time to discontinuation. Factors commonly associated with discontinuation
were added to the adjusted hazards model. These factors included type of baseline contracep-
tive method (short-acting/LARC), age and parity (continuous variables), displacement in the
past year (yes/no), education (none or some primary/completed primary or higher), marital
status (not married/married or living with partner) and desire for more children (wanted chil-
dren within two years, wanted children after two years or wanted no more children). The pro-
portional hazards assumption was investigated and no time variation was detected. To assess
possible problems of collinearity, separate analyses were run with parity and desire for more
children; because the results showed no significant differences, the results here present both
variables.
Results
A total of 548 contraceptive acceptors was interviewed (representing 70% of the women sought
or invited to come for an interview): 304 who started a short-acting method and 244 who
started a LARC in the 12–18 months prior to the interview. Table 1 shows that LARC acceptors
were slightly older than short-acting method acceptors (mean age 28.9 versus 27.5, p = .009).
Half of LARC acceptors (50.4%) reported having been displaced at least once in the previous
year compared to 36.5% of short-acting method acceptors (p = .001). No other socio-demo-
graphic differences were found among short- and long-acting contraceptive acceptors. In the
overall sample, most women were married or in union (82.7%) and half had no formal educa-
tion (51.1%). Mean gravidity for the women was 5.3 with a mean of 4.2 living children. The
vast majority of respondents wanted no more children (44.3%) or to wait more than two years
for their next pregnancy (36.3%). Women who accepted IUDs at baseline were older (mean
age 30.6 years compared to 27.4–27.7 years for the other method acceptors, p< .001), more
likely to have been displaced in the past year (60.4% compared to 27.6% - 43.4%, p< .001) and
had higher mean gravidity (6.0 compared to 4.9–5.3, p = .05) than other contraceptive method
acceptors.
Most women reported that their partner was aware of their contraceptive use (79.3%) and
approved (79.1%). Consistent with these results, 69.9% reported the decision to use contracep-
tion was made jointly with her partner while 27.0% reported it was primarily her decision.
Women reported the health center (78.6%) and community health workers (63.1%) as sources
of information about contraception. Before starting their baseline contraceptive, the vast
majority of the women (88.3%) had never used contraception. The main reasons given for
deciding to begin contraceptive use included wanting to delay pregnancy (85.4%), feeling tired
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Table 1. Characteristics of respondents, by baseline contraceptive method type.
Total acceptors (N = 548)
%(n)
Short-acting acceptors
(n = 304) %(n)




18–24 32.5% (178) 36.2% (110) 27.9% (68) p =
.017*
25–34 48.5% (266) 48.7% (148) 48.4% (118)
35–49 19.0% (104) 15.1% (46) 23.8% (58)
Mean age (SD), years 28.1 (6.3) 27.5 (6.1) 28.9 (6.5) p =
.009*
Displaced in last year (yes) 42.7% (234) 36.5% (111) 50.4% (123) p =
.001*
Marital status p = .938
Married, living with husband 82.7% (453) 82.2% (250) 83.2% (203)
Married, not living with husband 3.3% (18) 3.6% (11) 2.9% (7)
Not married, living with partner 1.8% (10) 1.6% (5) 2.0% (5)
Not married, not living with partner 12.2% (67) 12.5% (38) 11.9% (29)
Religion p = .598
Protestant 43.8% (240) 45.1% (137) 42.4% (103)
Catholic 16.1% (88) 16.1% (49) 16.0% (39)
Adventist 20.8% (114) 21.1% (64) 20.6% (50)
Pentecostal/Evangelical 17.0% (93) 16.4% (50) 17.7% (43)
Other or no religion 2.2% (12) 1.3% (4) 3.3% (8)
Formal education p = .607
None 51.1% (280) 50.5% (153) 52.0% (127)
Some primary school 18.4% (101) 17.8% (54) 19.3% (47)
Completed primary school 11.5% (63) 10.9% (33) 12.3% (30)
At least some secondary education 18.8% (103) 20.8% (63) 16.4% (40)
Gravidity (lifetime pregnancies)
0–1 5.5% (30) 6.6% (20) 4.1% (10) p = .360
2–4 38.9% (213) 40.5% (123) 36.9% (90)
5–9 46.4% (254) 44.7% (136) 48.4% (118)
10+ 9.3% (51) 8.2% (25) 10.7% (26)
Mean gravidity (SD) 5.3 (3.0) 5.13 (2.934) 5.61 (3.013) p = .063
Mean number of living children (SD) 4.2 (2.1) 4.1 (2.1) 4.3 (2.1) p = .301
Desire for more children p = .307
Within 2 years 18.1% (99) 20.3% (61) 15.8% (38)
After 2 years 36.3% (199) 34.6% (104) 39.6% (95)
Wants no more children 44.3% (243) 45.2% (136) 44.6% (107)
Partner is aware of contraceptive use 79.3% (405) 81.0% (230) 77.1% (175) p = .333
Partner approves of contraceptive use 79.1% (404) 81.0% (230) 76.7% (174) p = .277
Decision to start contraception p = .624
Joint decision 69.9% (380) 70.4% (212) 69.1% (168)
Primarily my decision 27.0% (147) 25.9% (78) 28.4% (69)
Primarily husband/partner 3.1% (17) 3.7% (11) 2.5% (6)
Source of information about contraception
Health center 78.6% (431) 80.9% (246) 75.8% (185) p = .179
Community health worker (CHW) 63.1% (346) 59.9% (182) 66.2% (164) p = .093
Radio 18.1% (99) 18.1% (55) 18.0% (44) p = 1.00
Husband/partner 7.8% (43) 9.5% (29) 5.7% (14) p = .138
(Continued )
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or having health problems (44.9%) or wanting no more children (19.3%). Women reported
that the provider discussed other contraceptive methods with them (93.4%), but that they
themselves decided which method to choose (89.4%). Overall, 76.1% of women reported that
the provider gave sufficient information at time of initiation. Satisfaction with the services
received when they started their contraceptive method was very high, with 93.6% reporting
complete satisfaction.
At 12 months, 81.6% of women reported using their baseline contraceptive method without
interruption, with more LARC acceptors than short-acting method acceptors (86.1% versus
78.0%, p = .02) continuing method use (Table 2). The most common reasons given for discon-
tinuation were that the women desired pregnancy (42.6%) or experienced side effects (32.7%).
Only one discontinuer reported stock-outs as the reason for discontinuing contraceptive
method use. Fig 2 presents the Kaplan-Meier survival curves, with separate curves for women
who started short-acting methods and LARCs (Breslow Wilcoxon test of equality of survivor
functions, p = .015); due to the low numbers of discontinuers, median time to discontinuation
could not be calculated. Use of a short-acting method was associated with discontinuation
within the first 12 months of use (HR 1.74 [95%CI 1.13–2.67]) when adjusted for age, parity,
displacement in the last year, education, marital status and desire for more children (Table 3).
Of these covariates, only desiring a child within two years (HR 2.58 [95%CI 1.45–4.54]) or
after two years (HR 1.9 [95%CI 1.12–3.22]) as compared to wanting no more children were
associated with discontinuation.
Of the 101 women who discontinued their baseline contraceptive method within 12
months, 55.4% stopped using any modern method for the remainder of the observation
period, 8.9% switched during the same month as stopping the previous method and 35.6%
switched sometime later during the observation period to another modern method. The
majority of the switchers (60.0%) switched to a contraceptive method of the same or similar
effectiveness; 28.9% switched to a more effective method and only 11.1% switched to a less
effective modern method (Table 4).
Continuing contraceptive users’ satisfaction
One-third (36.8%) of women using their contraceptive method at the time of the interview
reported having experienced problems with their method, primarily body or headaches
Table 1. (Continued)
Total acceptors (N = 548)
%(n)
Short-acting acceptors
(n = 304) %(n)
LARC acceptors (n = 244)
%(n)
p-value
Friend/family member 13.9% (76) 14.1% (43) 13.5% (33) p = .933
Community or religious leader 3.5% (19) 3.9% (12) 2.9% (7) P = .493
Ever used contraception before 11.7% (64) 12.5% (38) 10.7% (26) p = .593
Quality of information/counselling received
from providera
76.1% (415) 75.2% (227) 77.4% (188) p = .618
Complete satisfaction with services receivedb 93.6% (513) 93.4% (284) 93.9% (229) p = .976
*Test of significance p < .05
aIncludes responding yes that the provider explained how to use the contraceptive method, told her about possible side effects, explained what to do in case
of side effects and responded to all of her questions.
bIncludes being satisfied or very satisfied with the facility’s cleanliness, the providers’ friendliness, the amount of time spent at the facility, the privacy during
her time with the provider, the care she received, the respect shown to her by the provider and the expectation that the provider will keep her information
secret.
https://doi.org/10.1371/journal.pone.0182744.t001
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(69.4%) and menstrual changes (72.0%), and most of these women (89.8%) sought care at a
facility (Table 5). IUD users were less likely to report any problem (25.0% compared to 28.2%-
45.5% among other method users, p = .006), and least likely to report menstrual changes as a
problem (45.0% compared to 63.0%-83.1%, p < .003). Most women who sought care (89.8%)
reported that the problem was resolved to their satisfaction. Women reported high overall sat-
isfaction with their method (98.6%), and planned to continue their contraceptive use (98.8%).
Half of LARC users (52.0%) said they wanted to continue their method for five years or longer,
while half (52.5%) of short-acting method users projected using their method for two to four
years (p< .001). The majority of IUD users (61.0% compared to 29.4%-46.2%, p< .001)
reported wanting to continue method use for five years or more.
Discussion
More than 80% of women in this study were still using their baseline contraceptive method at
12 months. While continuation was higher among LARC acceptors than among short-acting
method acceptors, as expected, both percentages were higher than commonly found in other
studies [27, 30, 31]. Moreover, continuation was similarly high across age, education level and
displacement status. This program attracted new users of contraception (88.3% reported no
prior contraceptive use) and demonstrated that these new acceptors could also be supported,
as needed, to continue contraceptive use as long as they wished. This is the first study of con-
traceptive continuation in a humanitarian setting; these results provide evidence that effective
Table 2. Respondents’ baseline contraceptive method discontinuation and switching.
Total acceptors (N = 548)
%(n)
Short-acting acceptors (n = 304)
%(n)
LARC acceptors (n = 244)
%(n)
p-value




No 18.4% (101) 22.0% (67) 13.9% (34)
Yes 81.6% (447) 78.0% (237) 86.1% (210)
Total acceptors (n = 101) Short-acting acceptors (n = 67) LARC acceptors (n = 34)
Reason for discontinuing baseline method
Desired pregnancy 42.6% (43) 44.8% (30) 38.2% (13) p =
.678
Wanted to switch method 28.7% (29) 32.8% (22) 20.6% (7) p =
.292
Side effects 32.7% (33) 29.9% (20) 38.2% (13) p =
.532
Partner/family disliked 5.9% (6) 4.5% (3) 8.8% (3) p =
.669
Became pregnant while using 8.9% (9) 7.5% (5) 11.8% (4) p =
.480
Rumours/method bad for her 5.0% (5) 3.0% (2) 8.8% (3) p =
.332
Other reasons 5.9% (6) 7.5% (5) 2.9% (1) p =
.661
Switched to another modern method p =
.998
No 55.4% (56) 55.2% (37) 55.9% (19)
Yes, in the same month 8.9% (9) 9.0% (6) 8.8% (3)
Yes, after 1 month 35.6% (36) 35.8% (24) 35.3% (12)
*Test of significance p < .05
https://doi.org/10.1371/journal.pone.0182744.t002
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contraceptive programs that result in initiation and continuation can be successfully imple-
mented in such settings. Further, this evaluation lends support to the association between ser-
vice quality and contraceptive continuation [15]; the high percentages of women continuing
contraceptive use found here indicate that delivering high quality contraceptives services in
humanitarian settings is possible. As previously described, this program addressed Bruce’s six
elements of quality of care which appear to enhance contraceptive continuation.
Nearly half of the discontinuers switched to another modern contraceptive method during
the study period, although fewer than 10% did so within one month of stopping the baseline
method. The program could better assist women who wish to switch contraceptive methods to
do so immediately so they are not placed at risk of an unintended pregnancy. Of the disconti-
nuers who switched to a different contraceptive method during the study period, 60.0%
changed to a method of similar effectiveness and 28.9% switched to a more effective LARC.
This reflects the success the program is having with counseling and making a range of effective
short- and long-acting contraceptive methods available to this population.
While LARC acceptors were slightly older and more likely to have been displaced in the
last year, few differences in other socio-demographic characteristics between baseline
Fig 2. Kaplan-Meier survival curve for 12-month continuation of reversible contraceptives: Short-acting and LARC acceptors,
Breslow chi-square p = .015.
https://doi.org/10.1371/journal.pone.0182744.g002
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contraceptive method types were found. These data suggest that access to contraceptive meth-
ods is equitable and women choose the method they want. Displaced women may be more
likely to choose a LARC to avoid the need for resupply visits given the instability of their cur-
rent living situation. Few women reported previous contraceptive use, reinforcing the notion
that when good quality contraceptive services are put in place, women will use them, and may
in fact be highly motivated to continue use.
A recent analysis of evidence related to contraceptive discontinuation identified several key
programmatic strategies to reduce discontinuation: improving service quality, reducing pro-
vider bias and improving technical competence, eliminating stock-outs, increasing access
through multiple service delivery options and facilitating task sharing to lower level cadres
[15]. As described earlier, the program’s strong focus on quality improvement addressed many
of these issues which may therefore have contributed to the high continuation rates. For exam-
ple, only one woman reported discontinuation due to stock-outs, suggesting the program suc-
cessfully made the contraceptive methods consistently available. After some initial problems
with stock-outs, facility staff received additional training in stock management and forecast-
ing. Although insecurity and poor roads presented challenges to maintaining correct stock lev-
els, stock-outs at the health zone level were minimized.
Mid-level providers (nurses) were trained to provide all short- and long-acting contracep-
tive methods at health center level, thereby increasing access to them in this rural area. Clinical
Table 3. Unadjusted and adjusted hazard models predicting risk of discontinuation of baseline contraceptive method within first 12 months of
use.
Unadjusted HR (95%CI) p-value Adjusted HR (95%CI) p-value
Method type
Short-acting 1.65 (1.10–2.50) p = .017 1.74 (1.13–2.67) p = .012*
LARC 1 (reference) 1 (reference)
Age (years) .983 (.953–1.015) p = .305 .991 (.950–1.04) p = .687
Displaced in last year (yes) 1.25 (.846–1.85) p = .263 1.05 (.686–1.60) p = .832
Parity (no. of lifetime pregnancies) .995 (.932–1.06) p = .874 1.07 (.973–1.17) p = .172
Education (none or some primary) 1.36 (.856–2.17) p = .191 1.44 (.896–2.33) p = .132
Marital status (not married) 1.29 (.744–2.23) p = .367 1.61 (.899–2.9) p = .109
Desire for more children
Within 2 years 2.33 (1.40–3.89) p = .001 2.58 (1.45–4.54) p = .001*
After 2 years 1.62 (1.01–2.59) p = .045 1.90 (1.12–3.22) p = .017*
Wants no more children 1 (reference) 1 (reference)
*Test of significance p < .05
https://doi.org/10.1371/journal.pone.0182744.t003
Table 4. Status of discontinuers (n = 101).
Direction of change in efficacy Baseline method Switched to: n %
Discontinued contraceptive use (n = 56)
# Short-acting No method or traditional method 37 55.4%
LARC No method 19
Switched to another contraceptive method (n = 45)
# LARC Short-acting method 5 11.1%
 ! Short-acting Short-acting 17 60.0%
LARC LARC 10
" Short-acting LARC 17 28.9%
https://doi.org/10.1371/journal.pone.0182744.t004
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supervisors provided regular supportive supervision and had good supportive relationships
with facility staff with whom they identified problems and solutions together. To ensure tech-
nical competence, supervisors observed provider skills twice a year using a checklist and used
a database to track provider performance. Clinical supervisors used the data to develop indi-
vidual support based on each provider’s need. For example, few clients initially chose IUDs.
During supportive supervision visits, it was discovered that providers had had little opportu-
nity to practice after their initial training, and therefore lacked confidence in their skills and
thus underemphasized IUDs during counselling. Supervisors subsequently carried anatomic
models to their supervision visits to observe the providers’ skills and provide coaching. The
introduction of post-placental IUDs may have led to increases in IUD acceptance, by adding a
new service delivery option, as this method became more familiar to both providers and cli-
ents. Making all contraceptive methods available was important as a greater range of available
methods increases method choice, and is also associated with lower discontinuation [14].
In addition to improving provider competence, reducing provider bias is also associated
with higher continuation [15]. Few women in our sample were under 21 years old or unmar-
ried reflecting program review findings that some providers were uncomfortable providing
contraception or specific methods to adolescent and unmarried women. Values clarification
activities to discuss attitudes that were unfavourable to good quality care were conducted regu-
larly. Supervisors reinforced the need to treat all clients with respect and offer all women
informed choice. The program organized refresher trainings that focused specifically on coun-
selling skills and attitudes to ensure that the providers discussed the range of contraceptive
methods from which the woman could choose. The high satisfaction with provider explana-
tions during counselling may reflect the success of these efforts. These results also highlight the
Table 5. Continuing contraceptive users’ satisfactiona.
All users (N = 429) %
(n)
Short-acting users (n = 250)
%(n)
LARC users (n = 224)
%(n)
p-value
Experienced problem with current contraceptive method 36.8% (157) 40.1% (91) 33.0% (66) p = .130
Type of problem
Head or body aches 69.4% (109) 73.6% (67) 63.6% (42) p = .180
Nausea or vomiting 18.5% (29) 22.0% (20) 13.6% (9) p = .184
Menstrual changesb 72.0% (113) 82.4% (75) 57.6% (38) p =
.001*
Other problems 5.1% (8) 3.3% (3) 7.6% (5) p = .229
Sought care for problem at a health facility 89.8% (141) 91.2% (83) 87.9% (58) p = .496
Problem resolved to her satisfaction 92.1% (129) 93.9% (77) 89.7% (52) p = .358
Satisfied overall with method 98.6% (421) 99.6% (226) 97.5% (195) p = .071
Plans to continue method use 98.8% (422) 99.1% (225) 98.5% (197) p = .553
Projected time to continue current method use p <
.001*
Less than 2 years 9.2% (38) 12.8% (28) 5.1% (10)
2–4 years 48.0% (199) 52.5% (115) 42.9% (84)
5 or more years 42.9% (178) 34.7% (76) 52.0% (102)
Projected mean number of years to continue current
method use (SD)
3.7 (2.20) 3.3 (2.0) 4.1 (2.3) p <
.001*
aExcludes women who discontinued or switched methods after 12 months and before the interview date.
*Test of significance p < .05
bIncludes reports that periods stopped, increased or became irregular.
https://doi.org/10.1371/journal.pone.0182744.t005
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need for multi-year donor funding which permitted the program to focus on these quality
improvement activities once the basic services were in place.
It is notable that 71.3% of women reported reasons for discontinuing related to a change in
their own reproductive intention and not to program weaknesses, i.e., they desired pregnancy
or wanted to switch contraceptive methods. Consistent with other studies, side effects were
reported by one-third of both short-acting and LARC acceptors as a reason for discontinua-
tion, suggesting a need for additional support to providers to respond to side effects and to
improve initial counseling about them [11, 32]. Despite anecdotal evidence from program staff
and providers that rumors and misinformation in the community about contraception were
problems, only a few women mentioned these as reasons for discontinuation suggesting a suc-
cessful community education program.
The vast majority of participants reported learning about contraception from program
activities. The program trained CHWs as well as satisfied clients, peer educators, community
leaders and local community associations to conduct education about contraception in the
supported health zones. The broad range of community actors helped to reach men, which
may have contributed to the high rates of joint decision-making and partner approval in this
population. Community mobilization supervisors visited with the CHWs and provided coach-
ing on communications skills and different strategies to present and discuss key messages. In
addition, they helped the program to identify rumors about contraception in the community
and respond to them quickly. For those women who did not return for their next set of pills or
next injection, the facilities had a system that used CHWs to remind them of their missed
appointments. However, during data collection for this study, we found that male CHWs were
less helpful finding women using the available information. Female CHWs and providers were
more likely to know who their clients were. In DRC, most MOH-affiliated CHWs are male;
therefore, the system to promote continuation could be improved, particularly by involving
more women as CHWs. To address this gap, Save the Children trained and supported a cadre
of female peer educators and satisfied users.
Just over one in three contraceptive users who were using their method at the time of the
interview reported experiencing a problem with their method; short-acting method users were
more likely to report menstrual changes, especially increased menses, than LARC users. This is
consistent with other studies finding high levels of side effects reported by pill and injectable
users [11, 15, 33]. Since hormonal contraceptives represent nearly 90% of this program’s
method mix, supporting providers to respond to side effects is crucial. The program provided
extra coaching to providers on responding to side effects which may have contributed to the
low discontinuation as nine in ten women who sought care for their problem reported the
problem resolved. Although IUD discontinuers were as likely as other discontinuers to report
side effects as a reason for discontinuation of the method, continuing IUD users were least
likely to report any problem, and particularly a problem with menstrual changes, compared to
the other method users. This suggests that if women are supported through the early side
effects after IUD insertion, they end up reporting fewer problems with their method later on.
The high percentage (over 80%) of women who did not want to become pregnant within
two years likely also contributed to the high continuation. This program has successfully inte-
grated LARCs into their method mix, and clients are highly satisfied with the methods. It is,
however, notable that more than one in three short-acting method users said they wished to
continue contraceptive use for five or more years. In this rural area with far distances, poor or
non-existent roads, high insecurity and frequent displacement, these women may be interested
in switching to a LARC that does not require return visits to the facility every three months.
Further, nearly half of respondents reported wanting no more children, making them potential
candidates for sterilization. Now that sterilization is more available, the program should
Twelve-month contraceptive continuation in North Kivu, DRC
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improve education about permanent methods for those who are finished with child bearing.
Good quality services that ensure the availability of a range of short-acting, long-acting and
permanent contraceptive methods and encourage immediate switching among those who are
dissatisfied with their method allow women to exercise their reproductive choice.
Limitations
Due to insecurity and poor road access, a subset of supported facilities was identified from
which clients were selected rather than selecting the sample from all supported facilities. Cli-
ents from outside the catchment areas of the facilities were excluded; clients who lived far
from the facilities are underrepresented as they were more difficult to locate for interviews and
less likely to come when invited for an interview. Additional clients could not be found
because they had moved or traveled, or the information in the register was insufficient for the
CHWs to identify them. The sample is therefore not representative of all clients starting a con-
traceptive method at Save the Children-supported facilities in North Kivu. The lack of a com-
parison group makes it difficult to conclude the reasons for the high continuation found here.
Continuation may be overestimated in our sample as a woman could have reported continu-
ous use of pills or injectables even if she returned late for a subsequent dose. In addition, those
who lived furthest away from the facility, and may therefore have more difficulty returning for
the next dose of a short-acting method, are underrepresented. Due to low client numbers, cli-
ents from more than one month were selected to ensure sufficient sample size, meaning that
women were interviewed 13–19 months after beginning their method to ensure they had the
opportunity to use it for at least 12 months at the time of the interview. The data are therefore
subject to recall bias: women may have misremembered the timing or the circumstances sur-
rounding their starting, stopping or switching a contraceptive method. A retrospective study,
however, was the most feasible study design given the instability and insecurity in this setting
as well as the funding and time available. Courtesy bias may have affected the responses to the
service quality questions.
Conclusion
This study, the first to examine contraceptive continuation in a humanitarian setting, demon-
strates that women can be supported to continue use of their desired contraceptive method,
even in a difficult, unstable and low prevalence setting like North Kivu, where 82% of our sam-
ple continued method use at 12 months. A focus on service quality and efforts to address pro-
vider skills and ensure consistent availability of commodities likely contributed to the high
rates of contraceptive use and continuation. This highlights the need for multi-year funding in
humanitarian settings to enable this emphasis on quality improvement. While the program
has strengthened the health system in the province, the DRC health system is weak and contin-
ued donor support will be required in the future to ensure sustainability. When good quality
services, with a choice of short- and long-acting contraceptives, are in place, women will not
only choose to start, but also continue, to use contraception to exercise their right to reproduc-
tive choice.
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